No Prescription |
 |
 | ||
|
Coumadin Generic Warfarin |
|
| ||
No Prescription » Prescription Drugs 5 » Coumadin Generic Warfarin Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Treating or preventing blood clots that may occur in the veins and lungs. It is used to treat or prevent blood clots that may occur because of a certain type of abnormal heartbeat (atrial fibrillation) or heart valve replacement. It is also used to reduce the risk of death recurring heart attack or blood clotting events (eg stroke) after a heart attack. It may also be used for other conditions as determined by your doctor. Coumadin is an anticoagulant. It works by blocking the formation of ceratin blood clotting factors.Warfarin is an anticoagulant (blood thinner). Warfarin reduces the formation of blood clots. Warfarin is used to prevent heart attacks strokes and blood clots in veins and arteries.Anticoagulants decrease the clotting ability of the blood and therefore help to prevent harmful clots from forming in the blood vessels. These medicines are sometimes called blood thinners although they do not actually thin the blood. They also will not dissolve clots that already have formed but they may prevent the clots from becoming larger and causing more serious problems. They are often used as treatment for certain blood vessel heart and lung conditions. In order for an anticoagulant to help you without causing serious bleeding it must be used properly and all of the precautions concerning its use must be followed exactly. Be sure that you have discussed the use of this medicine with your doctor. It is very important that you understand all of your doctor's orders and that you are willing and able to follow them exactly. Coumadin is an anticoagulant (blood thinner). It is prescribed to:1. Prevent and/or treat a blood clot that has formed within a blood vessel or in the lungs. 2. Prevent and/or treat blood clots associated with certain heart conditions or replacement of a heart valve. 3. Aid in the prevention of blood clots that may form in blood vessels anywhere in the body after a heart attack. 4. Reduce the risk of death another heart attack or stroke after a heart attack. . Buy Coumadin Generic Warfarin and other Prescription Drugs 5 products online at Medstore. Buy Online at Medstore - Click Here!
About Coumadin Generic Warfarin: Product Type: Prescription Drugs 5 Coumadin ( Generic Warfarin ) Coumadin (Generic Warfarin) Generic Warfarin 10mg 28 Tabs 5mg 50 Tabs 1mg 50 Tablets 1mg 100(2 x 50) Tablets 2mg 50 Tablets 2mg 2 x 50 Tablets Generic Warfarin Coumadin
View more Prescription Drugs 5 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
